Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fredenburg
Ross A. Fredenburg, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090253655 | QUINOLINONE FARNESYL TRANSFERASE INHIBITORS FOR THE TREATMENT OF SYNUCLEINOPATHIES AND OTHER INDICATIONS - Novel quinolinone farnesyl transferase inhibitors are provided. These new compounds are useful in the treatment or prevention of synucleinopathies, such as Parkinson's Disease, Diffuse Lewy Body Disease, multiple system atrophy, and disorders of brain iron concentration including pantothenate kinase-associated neurodegeneration (e.g., PANK1), or other neurodegenerative/neurological diseases. Provided compounds are also useful in the treatment of proliferative diseases such as cancer, and in the treatment of neurological diseases, such as cognitive impairment, depression, and anxiety. | 10-08-2009 |
Ross A. Fredenburg, Rochester, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090118486 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS - The present invention discloses the existence of two novel proteins UspA1 and UspA2, and their respective genes uspA1 and uspA2. Each protein encompasses a region that is conserved between the two proteins and comprises an epitope that is recognized by the MAb 17C7. One or more than one of these species may aggregate to form the very high molecular weight form (i.e. greater than 200 kDa) of the UspA antigen. Compositions and both diagnostic and therapeutic methods for the treatment and study of | 05-07-2009 |
| 20090137788 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS - The present invention discloses the existence of two novel proteins UspA1 and UspA2, and their respective genes uspA1 and uspA2. Each protein encompasses a region that is conserved between the two proteins and comprises an epitope that is recognized by the MAb 17C7. One or more than one of these species may aggregate to form the very high molecular weight form (i.e. greater than 200 kDa) of the UspA antigen. Compositions and both diagnostic and therapeutic methods for the treatment and study of | 05-28-2009 |
Timothy Fredenburg, Pacifica, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090241041 | POSITION CODE BASED CONTENT DEVELOPMENT METHOD AND TOOL - Computerized content development methods and tools are disclosed. In one embodiment, a method includes generating a title by assigning one or more functions to respective portions of one or more position-coded pages through a graphical user interface which does not require a code level programming, and automatically converting the title to a format operable by computing device which interacts with a printed medium of the position-coded pages to perform the functions. | 09-24-2009 |